NUNZ
Price:
$0.003
Market Cap:
$1.30M
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-07-24
Stock Exchange
PNK
Ticker
NUNZ
According to Nunzia Pharmaceutical Company’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical ROE of Nunzia Pharmaceutical Company over the last ten years is 10.78%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), NUNZ's ROE was at its highest in in the December 2021 quarter at 82.83%. The ROE was at its lowest in in the March 2008 quarter at 0%.
Average
10.78%
Median
4.72%
Minimum
0%
Maximum
82.89%
Discovering the peaks and valleys of Nunzia Pharmaceutical Company ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual ROE = 82.89%
Minimum Annual Increase = -100.00%
Minimum Annual ROE = 0%
Year | ROE | Change |
---|---|---|
2022 | 0% | -100.00% |
2021 | 82.89% | 234.69% |
2020 | 24.77% | 16.52% |
2019 | 148.99% | 2.26% |
2018 | 6.32% | 33.42% |
2017 | 4.74% | 182.49% |
2009 | 1.68% | Infinity% |
2008 | 0% | -100.00% |
2007 | 4.12% | -12.34% |
2006 | 4.70% | -51.66% |
The current ROE of Nunzia Pharmaceutical Company (NUNZ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
35.89%
5-year avg
21.56%
10-year avg
10.78%
Nunzia Pharmaceutical Company’s ROE is less than Global WholeHealth Partners Corporation (0%), less than Stemsation International, Inc. (68.91%), greater than Home Bistro Inc. (-672.29%), greater than Pushfor Tech Inc. (-1043.37%), less than Cannabis Suisse Corp. (165.60%),
Company | ROE | Market cap |
---|---|---|
0% | $1.31K | |
68.91% | $1.59M | |
-672.29% | $90.00 | |
-1043.37% | $913.29K | |
165.60% | $1.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nunzia Pharmaceutical Company using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nunzia Pharmaceutical Company or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nunzia Pharmaceutical Company's ROE?
How is the ROE calculated for Nunzia Pharmaceutical Company (NUNZ)?
What is the highest ROE for Nunzia Pharmaceutical Company (NUNZ)?
What is the 3-year average ROE for Nunzia Pharmaceutical Company (NUNZ)?
What is the 5-year average ROE for Nunzia Pharmaceutical Company (NUNZ)?
How does the current ROE for Nunzia Pharmaceutical Company (NUNZ) compare to its historical average?